Dr. Dana Marie Roque, MD

Dr. Roque practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Roque's NPI, 1588869994, was assigned on June 16, 2007. Dr. Roque graduated from University of North Carolina at Chapel Hill School of Medicine in 2007. Dr. Roque holds Maryland license D0078133.

Dr. Roque's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Roque's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Roque is also affiliated with University of Maryland Baltimore Washington Medical Center. The medical group on file is UM Obstetrical and Gynecological Associates, PA.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roque practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Roque's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Roque's licenses on file in 3 states: Maryland, Connecticut and Pennsylvania.

CMS data shows 252 Medicare services from Dr. Roque across 5 procedure codes in 2024, for 132 Medicare patients. Medicare paid $19,768 for them.

CMS counts 132 Medicare patients who saw Dr. Roque in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roque's median patient age at 61, with 98% women.

In 2024, Dr. Roque wrote 542 Medicare Part D claims for 75 patients. 89% of them were for generic drugs. CMS names the drug for 306 of them, across 15 drugs with 11 or more claims each, at $270,335 in total drug cost. In 2023, CMS named 314 claims across 12 drugs.

Dr. Roque accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roque as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 57 papers to Dr. Roque, published from 2011 to 2024. 2021 was the busiest year, with 8. The most frequent topics are Ovarian Neoplasms, Uterine Neoplasms and Antineoplastic Agents. Dr. Roque has published most often in Cancers (Basel). Dr. Roque's most frequent co-authors are Alessandro D. Santin, MD, Elena S. Ratner, MD and Masoud Azodi, MD.

Dmand AI links Dr. Roque to 7 clinical trials, 4 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Ovarian Neoplasms, Carcinoma, Ovarian Epithelial and Fallopian Tube Diseases. NRG Oncology sponsors the most, 2.

CMS Open Payments shows 22 general payments to Dr. Roque from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 71% of the total. Intuitive Surgical, Inc. paid the most, $1,880.

Dr. Roque graduated from University of North Carolina at Chapel Hill School of Medicine in 2007.